Defense Secretary Pete Hegseth Wants to Use Taxpayer Dollars to Screen Troops for Low Testosterone.
Pete Hegseth, the embattled Defense Secretary, has outlined plans to deploy a sweeping screening program targeting troops over 30 for “testosterone deficiency.” This comes via a Wednesday video posted on X, where Hegseth pitched the initiative as “The High-T Department of War.”
Hegseth frames the move as a vital measure to ensure the military is equipped with the best fit-for-duty personnel. The screening program, which has yet to detail its exact scope and timeline, aims to identify soldiers struggling with low testosterone levels, supposedly a hindrance to their effectiveness on the battlefield.
Testosterone and Military Performance
The relationship between testosterone and military performance is complex. While low testosterone levels have been linked to decreased motivation, reduced strength, and lowered morale, the military’s own research suggests that testosterone levels don’t directly correlate with combat effectiveness. A 2019 study published in the Journal of Clinical Endocrinology and Metabolism found no significant connection between low testosterone and military performance.
Who’s Behind This Move?
Pete Hegseth, the man pushing this initiative, has a history of advocating for military personnel with hormone deficiencies. Prior to his appointment as Defense Secretary, Hegseth was a vocal supporter of low-testosterone treatments for troops. Critics argue that Hegseth’s push for low-testosterone treatments stems from a personal connection – he has publicly spoken about his own struggles with low testosterone.
What This Means for Taxpayers
The proposed screening program and subsequent treatments for low testosterone among troops will undoubtedly put a significant strain on taxpayer dollars. The exact cost remains unknown, but with millions of active-duty personnel, the potential financial burden could be substantial. With the DoD already facing budget cuts, lawmakers will be under pressure to scrutinize the efficacy and necessity of this program, particularly considering the limited scientific evidence supporting its benefits.
